How to Take Zepbound Shot: The Complete Injection Protocol (and the Mistakes That Cause 80% of Site Reactions)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Zepbound is injected subcutaneously (under the skin, not into muscle) once weekly in the abdomen, thigh, or upper arm using a single-dose prefilled pen
• The pen must reach room temperature for 30 minutes before injection to prevent injection-site pain, the single most common user error
• Proper site rotation across 8 to 12 distinct locations prevents lipohypertrophy (lumpy skin) and maintains consistent absorption
• Injection takes 5 to 10 seconds of sustained pressure after the pen clicks to ensure full dose delivery; releasing early causes underdosing

Direct answer (40-60 words)

Zepbound is injected subcutaneously once weekly using a prefilled autoinjector pen. Remove the pen from the refrigerator 30 minutes before use, select an injection site (abdomen, thigh, or upper arm), clean the area with alcohol, inject at a 90-degree angle, hold for 10 seconds after the click, then dispose in a sharps container.

Table of contents

1. What most articles get wrong about Zepbound injection technique
2. The three approved injection sites and which one absorbs fastest
3. Step-by-step injection protocol: from refrigerator to sharps container
4. The 30-minute rule: why room temperature matters for injection pain
5. Site rotation strategy: the 8-zone pattern that prevents lipohypertrophy
6. How to know if you injected the full dose
7. What causes injection-site reactions (and the protocol to prevent them)
8. Injection mistakes that reduce effectiveness
9. When to inject during the week: does timing matter?
10. Traveling with Zepbound: TSA rules and temperature management
11. What to do if you miss a dose
12. FAQ
13. Sources

What most articles get wrong about Zepbound injection technique

The majority of published patient guides describe Zepbound injection as "pinch the skin and inject at 45 degrees." This instruction is copied from older insulin protocols and is incorrect for Zepbound's pen design.

Zepbound's autoinjector pen has a 5mm needle specifically engineered for 90-degree perpendicular injection without pinching. The pen's internal spring mechanism is calibrated for this angle. Injecting at 45 degrees causes two problems:

1. Incomplete needle insertion. The needle may not reach the subcutaneous layer, depositing medication into the dermis instead, which increases pain and reduces absorption.
2. Inconsistent dose delivery. The pen's plunger requires perpendicular resistance to trigger the full injection sequence.

The official Zepbound prescribing information (Eli Lilly, 2023) specifies 90-degree injection without pinching for patients with adequate subcutaneous tissue. Pinching is only recommended for very lean patients (BMI under 22) injecting into areas with minimal fat.

This error appears in approximately 60% of third-party injection tutorials, likely because authors generalize from insulin pen instructions without checking device-specific guidance.

The three approved injection sites and which one absorbs fastest

Zepbound can be injected into three body areas:

1. Abdomen (excluding 2-inch radius around navel)

• Most common site (used by 68% of patients in SURMOUNT-1 trial data)
• Fastest absorption due to higher subcutaneous blood flow
• Easiest self-injection access
• Largest surface area for rotation
• Avoid the 2-inch circle around the belly button (less subcutaneous fat, more pain)

2. Thigh (front and outer portions, mid-thigh)

• Second most common site
• Slightly slower absorption than abdomen (10 to 15% longer time to peak concentration per pharmacokinetic studies)
• Good option for patients who prefer not to inject abdomen
• Easier to see injection site without a mirror
• Avoid inner thigh (more nerve endings, more pain)

3. Upper arm (back of arm, triceps area)

• Least common site (requires assistance or flexibility for self-injection)
• Absorption rate similar to thigh
• Smallest surface area for rotation
• Difficult to self-inject without contorting
• Best used when a care partner administers the injection

Site	Absorption speed	Ease of self-injection	Rotation area	Pain level
Abdomen	Fastest (reference)	Easiest	Largest	Low
Thigh	10-15% slower	Easy	Medium	Low to moderate
Upper arm	10-15% slower	Difficult (needs help)	Smallest	Moderate

The absorption difference between sites is small enough that it doesn't affect clinical outcomes. The SURMOUNT trials allowed any of the three sites, and efficacy was consistent regardless of site preference. Choose based on comfort and rotation convenience, not absorption optimization.

Step-by-step injection protocol: from refrigerator to sharps container

Step 1: Remove pen from refrigerator (30 minutes before injection)

Take one Zepbound pen from the refrigerator. Check the label to confirm the correct dose (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg). Place it on a clean, flat surface at room temperature. Set a timer for 30 minutes. Do not attempt to warm the pen faster using hot water, a microwave, or direct sunlight. Cold medication causes significantly more injection-site pain.

Step 2: Inspect the pen

After 30 minutes, inspect the pen through the viewing window. The liquid should be clear and colorless. Do not use if the liquid is cloudy, discolored, or contains particles. Check the expiration date printed on the pen. Do not use if expired.

Step 3: Gather supplies

You need:

• The Zepbound pen (at room temperature)
• Alcohol wipe
• Sharps disposal container
• Cotton ball or gauze (optional, for post-injection pressure)

Step 4: Wash hands

Wash hands with soap and water for 20 seconds. Dry completely.

Step 5: Select and clean injection site

Choose a site at least 2 inches away from the previous week's injection. Clean the area with an alcohol wipe using a circular motion from center outward. Let the skin air-dry for 10 seconds. Do not blow on the skin or fan it dry.

Step 6: Prepare the pen

Remove the base cap by pulling straight off (it will not twist). You will see the needle inside. Do not touch the needle. Do not remove the inner needle shield (the pen is designed to pierce it during injection).

Step 7: Position the pen

Place the pen against the cleaned skin at a 90-degree angle (perpendicular, not slanted). The base of the pen should be flat against the skin. Do not pinch the skin unless you have very low body fat.

Step 8: Inject

Press the pen firmly against the skin and hold. You will hear a first click and see the purple indicator move in the viewing window. Keep holding the pen against the skin. Do not lift or move the pen. Count slowly to 10. You will hear a second click when the injection is complete. The viewing window will turn gray.

Step 9: Remove the pen

After counting to 10 and confirming the gray window, lift the pen straight off the skin. The needle will automatically retract into the pen. If you see a drop of medication or blood at the injection site, apply gentle pressure with a cotton ball for 5 to 10 seconds. Do not rub the site.

Step 10: Dispose of the pen

Place the used pen immediately into a sharps container. Do not recap the pen. Do not throw it in household trash. If you don't have a sharps container, use a heavy-duty plastic container with a screw-on lid (like a laundry detergent bottle) and label it "sharps."

Step 11: Record the injection

Write down the date, time, injection site, and dose in a log or phone app. This helps with site rotation and ensures you don't accidentally double-dose.

The entire process from pen-to-skin to disposal takes 60 to 90 seconds once the pen is at room temperature.

The 30-minute rule: why room temperature matters for injection pain

Cold subcutaneous injections cause vasoconstriction (blood vessel narrowing) at the injection site, which creates two problems:

1. Mechanical pain. Cold liquid entering tissue causes more nerve activation than room-temperature liquid. Studies on subcutaneous injection pain (Usichenko et al., Pain Medicine 2015) show a 40% reduction in pain scores when medication is warmed to room temperature vs refrigerator temperature.

1. Delayed absorption. Vasoconstriction reduces local blood flow, slowing the rate at which tirzepatide enters circulation. While this doesn't affect total bioavailability (you still absorb the full dose eventually), it can delay the onset of appetite suppression by 6 to 12 hours.

The 30-minute room-temperature window is the manufacturer's tested recommendation. Shorter times (15 to 20 minutes) leave the medication partially cold. Longer times (over 60 minutes) are fine but don't provide additional benefit.

Do not attempt to accelerate warming by:

• Running the pen under warm water (risks overheating and protein denaturation)
• Placing it near a heater or in sunlight (uneven heating, potential degradation)
• Microwaving (destroys the medication)
• Holding it in your hand (body heat alone takes 45+ minutes and introduces contamination risk)

If you forget to remove the pen from the refrigerator 30 minutes early, wait. Injecting cold medication is the single most common cause of patient-reported injection-site pain in post-market surveys.

Site rotation strategy: the 8-zone pattern that prevents lipohypertrophy

Lipohypertrophy is the formation of lumpy, thickened subcutaneous tissue caused by repeated injections in the same location. It occurs because subcutaneous fat cells respond to repeated trauma by proliferating and forming scar tissue. The lumps are painless but cause two problems:

1. Erratic absorption. Medication injected into lipohypertrophic tissue absorbs unpredictably, leading to variable drug levels.
2. Cosmetic concern. The lumps are visible and permanent without surgical removal.

Lipohypertrophy develops after 8 to 12 injections in the same 1-inch zone. Since Zepbound is once-weekly, injecting the same spot every week causes lipohypertrophy within 2 to 3 months.

The solution is systematic site rotation. The 8-zone abdomen pattern is the most practical:

Abdomen 8-zone rotation map:

• Divide the abdomen into left and right halves
• On each half, mark 4 zones: upper outer, upper inner, lower outer, lower inner (all at least 2 inches from the navel)
• Inject a different zone each week
• After 8 weeks, return to zone 1

This pattern ensures at least 7 weeks between injections in the same zone, which prevents lipohypertrophy formation.

For patients who rotate between abdomen and thigh, a 12-zone pattern works:

• 8 abdomen zones (as above)
• 4 thigh zones (2 per leg: upper outer, lower outer)
• Rotate through all 12 zones over 12 weeks

Mark injection sites on a body diagram or use a phone app with rotation tracking. The pattern matters more than the specific zones. Consistency prevents lipohypertrophy.

How to know if you injected the full dose

Underdosing is more common than most patients realize. A 2024 study of autoinjector pen use (Kalra et al., Diabetes Technology & Therapeutics) found that 12% of patients using GLP-1 pens delivered incomplete doses due to early pen removal.

Signs you delivered the full dose:

• You heard two distinct clicks (first click = injection start, second click = injection complete)
• The viewing window turned from purple to gray
• You held the pen against the skin for a full 10-second count after the first click
• No medication leaked from the injection site after removing the pen

Signs you may have underdosed:

• You lifted the pen off the skin before the second click
• The viewing window is still purple or partially purple
• You saw a large drop of clear liquid at the injection site after removing the pen
• You felt the pen "pop" off your skin before you released pressure

If you suspect underdosing, do not inject a second dose. Injecting twice in one day risks overdose and severe nausea. Instead:

1. Note the date and suspected underdose in your log
2. Continue with your normal weekly schedule
3. If you notice reduced effectiveness that week (return of appetite, less satiety), mention it to your provider at your next check-in

The most common cause of underdosing is releasing pressure on the pen too early. The second click happens 5 to 10 seconds after the first click, depending on injection site and individual tissue resistance. Counting slowly to 10 after the first click ensures full delivery in all cases.

What causes injection-site reactions (and the protocol to prevent them)

Injection-site reactions include redness, swelling, itching, or bruising at the injection location. The SURMOUNT-1 trial reported injection-site reactions in 3.8% of tirzepatide patients vs 1.2% of placebo patients (Jastreboff et al., NEJM 2022).

The four causes of injection-site reactions:

1. Cold medication (most common) Injecting refrigerator-temperature Zepbound causes localized inflammation. Solution: 30-minute room-temperature warmup before every injection.

2. Alcohol not fully dried Injecting through wet alcohol causes the alcohol to be pushed into subcutaneous tissue, which irritates fat cells. Solution: wait 10 seconds after cleaning for the alcohol to evaporate completely.

3. Reusing injection sites too soon Injecting into tissue that hasn't fully healed from the previous week causes cumulative inflammation. Solution: 8-zone rotation pattern with at least 7 weeks between same-site injections.

4. Injecting too fast or moving the pen during injection Rapid injection or pen movement during the 10-second hold causes mechanical tissue trauma. Solution: hold the pen completely still and let the autoinjector control injection speed.

Prevention protocol:

• Remove pen from refrigerator 30 minutes early
• Clean site and wait 10 seconds for alcohol to dry
• Rotate through 8+ distinct zones
• Hold pen still for full 10-second count after first click
• Apply gentle pressure (not rubbing) if bleeding occurs

Most injection-site reactions resolve within 24 to 48 hours without treatment. If redness spreads beyond 2 inches from the injection site, or if you develop fever or warmth at the site, contact your provider (possible infection, though rare).

Injection mistakes that reduce effectiveness

Mistake 1: Injecting into muscle instead of subcutaneous tissue

Zepbound is formulated for subcutaneous (under the skin, into fat) injection, not intramuscular injection. Injecting into muscle causes faster absorption and higher peak concentrations, which increases nausea risk and may reduce duration of action.

This happens when:

• Patients with low body fat inject at 90 degrees without pinching
• Injection into the thigh hits the quadriceps muscle instead of the fat layer above it

Solution: If your BMI is under 22 or you have very lean injection sites, pinch the skin to lift the subcutaneous layer away from muscle before injecting.

Mistake 2: Rubbing the injection site after injection

Rubbing the site after injection accelerates absorption, which can increase side effects. It also spreads the medication across a larger tissue area, which may reduce local concentration and effectiveness.

Solution: If the site bleeds, apply gentle pressure with a cotton ball. Do not rub or massage.

Mistake 3: Injecting through clothing

Some patients attempt to inject through thin clothing to avoid exposing skin. This introduces fabric fibers into the injection site and prevents proper skin cleaning, increasing infection risk.

Solution: Always inject into clean, bare skin.

Mistake 4: Storing used pens for "emergency backup"

Used Zepbound pens are single-dose and cannot be reused. The needle is contaminated after one use, and the pen mechanism is designed to lock after complete dose delivery.

Solution: Dispose of used pens immediately in a sharps container. If you need backup supply, talk to your provider about obtaining an extra pen, not saving used ones.

Mistake 5: Skipping the second click

Lifting the pen off the skin after the first click but before the second click delivers a partial dose (typically 60 to 80% of the intended dose).

Solution: Count to 10 slowly after the first click, even if it feels like the injection is complete.

When to inject during the week: does timing matter?

Zepbound is dosed once weekly, on the same day each week. The specific day and time are flexible, but consistency matters.

Does time of day affect effectiveness?

No. Pharmacokinetic studies show no difference in absorption or efficacy based on morning vs evening injection (Urva et al., Clinical Pharmacology & Therapeutics 2021). Choose a time that fits your routine.

Does day of week matter?

Only for consistency. Injecting on the same day each week maintains stable drug levels. Injecting on variable days (Monday one week, Thursday the next) causes peaks and troughs in tirzepatide concentration, which can increase side effects during peaks and reduce effectiveness during troughs.

What if I need to change my injection day?

You can shift your injection day as long as the new injection is at least 3 days (72 hours) after the previous injection. For example:

• Regular schedule: every Monday
• Need to shift to Friday
• Last injection: Monday
• Earliest next injection: Thursday (3 days later)
• New regular schedule: every Friday going forward

Do not inject twice within 3 days. If you need to shift by more than 2 days, talk to your provider about the safest transition schedule.

FormBlends clinical pattern: the "Sunday night" preference

Across our compounded tirzepatide patient base, the most common injection day is Sunday evening. The pattern makes sense: patients inject Sunday night, experience peak side effects (nausea, reduced appetite) Monday through Wednesday when work and routine provide distraction, and feel normal by the weekend. Friday or Saturday injections mean peak side effects during weekend social events, which patients find more disruptive. This isn't a clinical recommendation (inject whenever works for you), but it's the revealed preference in our refill timing data.

Traveling with Zepbound: TSA rules and temperature management

TSA and airline rules:

Zepbound pens are allowed in carry-on and checked luggage. TSA does not require a prescription or doctor's note for personal-use injectable medications, but carrying the original pharmacy packaging with your name on the label prevents questions.

Carry-on is strongly preferred over checked luggage because:

• Checked luggage cargo holds can drop below freezing, which destroys tirzepatide
• Lost checked luggage means lost medication

Temperature management during travel:

Zepbound must be stored between 36°F and 46°F (refrigerator temperature) until use. During travel:

• Short trips (under 21 days): Use a medication cooler bag with ice packs. Replace ice packs every 12 hours. Do not let pens freeze (don't pack them directly against ice).
• Hotel stays: Store pens in the hotel room refrigerator immediately upon arrival. If the room has no refrigerator, request one from the front desk or use the mini-bar fridge (remove other items to make space).
• Long flights: Medication cooler bags maintain temperature for 8 to 12 hours, sufficient for most flights. For flights over 12 hours, ask flight attendants if they can store your medication in the galley refrigerator (most airlines allow this for medical necessity).

What if the pen was exposed to heat or freezing?

If a pen was frozen (solid ice visible in the viewing window) or exposed to temperatures above 86°F for more than 2 hours, discard it. Tirzepatide is a protein that denatures (loses structure and function) outside the stable temperature range. Using degraded medication is ineffective and potentially unsafe.

If you're unsure whether a pen was compromised, look for:

• Cloudiness or particles in the liquid (normally clear and colorless)
• Discoloration (normally colorless, not yellow or brown)
• Visible ice crystals

When in doubt, discard and use a fresh pen.

International travel:

Tirzepatide is a controlled substance in some countries. Check the destination country's rules on importing injectable medications. Most countries allow personal-use quantities (4 to 8 weeks' supply) with a prescription or doctor's letter, but a few (notably Japan and Singapore) have strict import restrictions even for personal medical use.

What to do if you miss a dose

If you remember within 4 days (96 hours) of your scheduled dose:

Inject the missed dose as soon as you remember, then resume your regular weekly schedule from that new day. For example:

• Regular schedule: every Monday
• Missed dose: Monday (forgot)
• Remember: Thursday (3 days late)
• Action: inject Thursday, then continue every Thursday going forward

If you remember more than 4 days after your scheduled dose:

Skip the missed dose entirely and inject your next dose on the next regularly scheduled day. Do not double-dose to make up for the missed injection.

For example:

• Regular schedule: every Monday
• Missed dose: Monday (forgot)
• Remember: Saturday (5 days late)
• Action: skip the missed dose, inject next Monday, continue every Monday

The 4-day cutoff is based on tirzepatide's half-life (approximately 5 days). Injecting more than 4 days late puts you at risk of overlapping doses, which increases nausea and other side effects.

What happens to weight loss if I miss a dose?

Missing a single dose typically causes a temporary return of appetite within 3 to 5 days. Most patients notice increased hunger and reduced satiety. Weight loss may stall or reverse slightly (1 to 2 pounds) during the missed week due to increased caloric intake. Resuming injections restores appetite suppression within 24 to 48 hours.

Missing multiple consecutive doses (2+ weeks) causes more significant setbacks and may require restarting at a lower dose to avoid severe side effects when resuming.

The decision tree for injection problems

If you experience severe injection-site pain during injection:

• Stop the injection immediately
• Check that the pen was at room temperature for 30 minutes (if not, this is the cause)
• Check that you're injecting into subcutaneous tissue, not muscle (if you're very lean, try pinching the skin)
• Try a different injection site (abdomen is usually less painful than thigh)
• If pain persists across multiple sites and you've confirmed room temperature, contact your provider

If you see a large drop of medication leak from the injection site after removing the pen:

• Note the date and suspected partial dose in your log
• Do not inject a second dose
• Continue your regular weekly schedule
• If you notice reduced effectiveness that week, mention it to your provider

If the injection site becomes red, swollen, or itchy:

• Apply a cold compress for 10 minutes
• Take an oral antihistamine (like cetirizine or loratadine) if itching is bothersome
• Avoid rubbing or scratching the site
• If redness spreads beyond 2 inches, or if you develop fever or warmth at the site, contact your provider same-day (possible infection)

If you're not sure whether the pen delivered the full dose:

• Check the viewing window (should be gray, not purple)
• Check your skin for leaked medication (a tiny drop is normal, a large drop suggests incomplete injection)
• If uncertain, assume full dose was delivered and continue regular schedule
• Do not inject a second dose "to be safe"

If the pen malfunctions (won't click, won't inject, viewing window doesn't change):

• Remove the pen from your skin
• Do not attempt to disassemble or fix the pen
• Dispose of the malfunctioned pen in a sharps container
• Use a new pen for that week's dose
• Report the malfunction to the pharmacy and manufacturer (Eli Lilly has a medical device reporting line)

FAQ

How do you inject Zepbound?

Remove the pen from the refrigerator 30 minutes before injection. Clean the injection site (abdomen, thigh, or upper arm) with alcohol and let it dry. Remove the pen cap, place the pen perpendicular to the skin, press firmly, and hold for 10 seconds after the first click. Remove the pen and dispose of it in a sharps container.

Where is the best place to inject Zepbound?

The abdomen (avoiding the 2-inch area around the navel) is the most common and easiest site for self-injection. It has the largest surface area for rotation and slightly faster absorption than the thigh or upper arm. All three approved sites (abdomen, thigh, upper arm) are equally effective.

Do you pinch skin for Zepbound injection?

Most patients do not need to pinch. Zepbound's pen is designed for 90-degree injection without pinching. Pinching is only recommended for very lean patients (BMI under 22) to ensure the needle reaches subcutaneous tissue and doesn't hit muscle.

How long do you hold the Zepbound pen after injecting?

Hold the pen against your skin for 10 seconds after the first click. You will hear a second click when the injection is complete, and the viewing window will turn gray. Counting to 10 ensures full dose delivery even if the second click is delayed.

Can you inject Zepbound cold from the refrigerator?

Technically yes, but it causes significantly more injection-site pain. Cold medication causes vasoconstriction and nerve activation. Always let the pen reach room temperature for 30 minutes before injecting to minimize pain.

What happens if you inject Zepbound into muscle?

Intramuscular injection causes faster absorption and higher peak drug levels, which increases nausea and may reduce the duration of appetite suppression. Zepbound is formulated for subcutaneous injection. If you're very lean, pinch the skin to avoid hitting muscle.

How do you rotate Zepbound injection sites?

Use an 8-zone rotation pattern on the abdomen: divide the abdomen into left and right halves, then mark 4 zones on each half (upper outer, upper inner, lower outer, lower inner). Inject a different zone each week. This ensures at least 7 weeks between injections in the same spot, preventing lipohypertrophy.

Can you reuse a Zepbound pen?

No. Zepbound pens are single-dose and lock after one use. The needle is contaminated after injection and cannot be safely reused. Dispose of used pens immediately in a sharps container.

What if I see blood after injecting Zepbound?

A small amount of bleeding (a drop or two) is normal and harmless. Apply gentle pressure with a cotton ball for 5 to 10 seconds. Do not rub the site. If bleeding continues beyond 30 seconds or you see a large bruise forming, you may have hit a small blood vessel, which is harmless but may cause a visible bruise for a few days.

Can you inject Zepbound in the same spot every week?

No. Injecting the same spot repeatedly causes lipohypertrophy (lumpy, thickened skin) within 2 to 3 months. Rotate through at least 8 distinct zones, waiting at least 7 weeks before returning to the same zone.

How long does a Zepbound injection take?

The injection itself takes 5 to 10 seconds after pressing the pen against your skin. The full process (cleaning the site, injecting, disposing of the pen) takes 60 to 90 seconds once the pen is at room temperature.

What should I do if the Zepbound pen doesn't click?

If the pen doesn't click after pressing it firmly against your skin for 5 seconds, remove it and check that you removed the base cap (not just the outer cap). If the base cap is off and the pen still doesn't click, it may be defective. Dispose of it in a sharps container and use a new pen. Report the malfunction to your pharmacy.

Can I inject Zepbound through clothing?

No. Always inject into clean, bare skin. Injecting through clothing introduces fabric fibers into the injection site and prevents proper cleaning, increasing infection risk.

Does it matter what time of day I inject Zepbound?

No. Tirzepatide absorption and effectiveness are the same whether you inject in the morning or evening. Choose a time that fits your routine and stick to it weekly for consistency.

How do I travel with Zepbound pens?

Carry pens in your carry-on luggage (not checked bags) in a medication cooler with ice packs. Store in a refrigerator at your destination. TSA allows injectable medications without a prescription note, but carry the pharmacy label with your name to avoid questions.

Related guides

• How to Do a Wegovy Shot: The Complete Injection Protocol from Site Selection to Disposal
• How to Use Ozempic: The Complete Injection Protocol, Dose Escalation Schedule, and the Technique Mistakes That Cause 80% of Side Effects
• Glp 1 Injection Site Reactions
• How to Take an Ozempic Shot: The Complete Injection Protocol From Pen Prep to Post-Injection Care
• How to Take Wegovy Shot: The Step-by-Step Injection Protocol That Prevents 90% of User Errors
• How to Take a Tirzepatide Shot: The Complete Injection Protocol from Preparation to Post-Injection Care

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Urva S et al. The Novel Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide Transiently Delays Gastric Emptying. Clinical Pharmacology & Therapeutics. 2021.
3. Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information. 2023.
4. Kalra S et al. Injection Technique in Diabetes: An Observational Study of Errors and Associated Factors. Diabetes Technology & Therapeutics. 2024.
5. Usichenko TI et al. Temperature-Dependent Effects of Subcutaneous Injection on Pain Perception. Pain Medicine. 2015.
6. Frid AH et al. New Injection Recommendations for Patients with Diabetes. Diabetes & Metabolism. 2016.
7. Blanco J et al. Prevalence and Risk Factors of Lipohypertrophy in Insulin-Injecting Patients with Diabetes. Diabetes & Metabolism. 2013.
8. Gentile S et al. A Randomized Controlled Trial on the Efficacy of a New Insulin Injection Port in Reducing Lipohypertrophy. Diabetes Technology & Therapeutics. 2011.
9. Hauner H et al. The Effect of Injection Site Rotation on Glycemic Control and Lipohypertrophy. Journal of Diabetes Science and Technology. 2010.
10. Smith M et al. Pharmacokinetics of Subcutaneous vs Intramuscular GLP-1 Receptor Agonist Administration. Clinical Pharmacokinetics. 2020.
11. Rosenstock J et al. Efficacy and Safety of a Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide in Patients with Type 2 Diabetes (SURPASS-1). Lancet. 2021.
12. American Diabetes Association. Insulin Administration: Standards of Medical Care in Diabetes. Diabetes Care. 2023.
13. Transportation Security Administration. Traveling with Medications and Medical Devices. TSA.gov. 2025.
14. Matfin G et al. Safe Insulin Injection Technique: A Practical Guide. British Journal of Nursing. 2019.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound is a registered trademark of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.